Post Marketing Surveillance Study To Observe Safety And Efficacy Of Sutene
NCT ID: NCT00444795
Last Updated: 2017-02-01
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
520 participants
OBSERVATIONAL
2007-05-31
2015-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Special Investigation For Gist Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan).
NCT00716820
Post Marketing Surveillance On The Safety And Tolerability Of Sunitinib Malate (Sutent) For Filipino Patients
NCT01073644
A Phase I/II Study of Sunitinib Malate (SU011248) In Patients With Gastrointestinal Stromal Tumor (GIST)
NCT00457743
A Study of Sunitinib In Young Patients With Advanced Gastrointestinal Stromal Tumor
NCT01396148
Non-Interventional Retrospective Correlation Of Tumor Mutational Status To Clinical Benefit Of GIST Patients Treated With Sunitinib
NCT01459757
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
patients diagnosed as GIST after disease progression on or intolerance to imatinib mesylate
Sunitinib malate
Sunitinib : dosing not pre-determined
2
patients diagnosed as advanced RCC
Sunitinib malate
Sunitinib : dosing not pre-determined
3
patients diagnosed as unresectable, well-differentiated advanced and/or metastatic pancreatic neuroendocrine carcinoma
sunitinib malate
Sunitinib : dosing not pre-determined
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sunitinib malate
Sunitinib : dosing not pre-determined
Sunitinib malate
Sunitinib : dosing not pre-determined
sunitinib malate
Sunitinib : dosing not pre-determined
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with hypersensitivity to sunitinib malate or to any other component of Sutent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Keimyung University Dongsan Medical Center
Jung-gu, Daegu, South Korea
Daegu Catholic University Medical Center
Nam-gu, Daegu, South Korea
GangNeung Asan Hospital
Gangneung-si, Gangwon-do, South Korea
Soonchunhyang University Bucheon Hospital
Bucheon-si, Gyeonggi-do, South Korea
The Catholic University of Korea, St. Vincent's Hospital
Suwon, Gyeonggi-do, South Korea
Seoul National University Hospital (SNUH)
Seoul, Seoul, South Korea
Hwasun Hospital, Chonnam National University
Cheonnam, South Jeolla Province, South Korea
Hallym University Sacred Heart Hospital
Anyang, , South Korea
Pusan National University Hospital
Busan, , South Korea
Kosin University Gospel Hospital
Busan, , South Korea
Dong-A University Hospital
Busan, , South Korea
Dong-A University Medical Center (Dong-A University Hospital)
Busan, , South Korea
Dong-A University Medical Center, Department of Medicine, Division of Hemato-Oncology
Busan, , South Korea
Pusan National University Hospital
Busan, , South Korea
Hwasun Hospital, Chonnam National University
Cheonnam, , South Korea
Keimyung University Dongsan Hospital
Daegu, , South Korea
Kyungpook National University Medical Center
Daegu, , South Korea
Daegu Catholic University Medical Center (DCUMC)
Daegu, , South Korea
Chungnam National University Hospital
Daejeon, , South Korea
Eulji University Hospital
Daejeon, , South Korea
Inje University Ilsan Paik Hospital
Goyang, , South Korea
Chosun University Hospital
Gwang Joo, , South Korea
Pusan National University Hospital
Gyeongsangnam-do, , South Korea
Wonkwang University School of Medicine and Hospital (WUH)
Iksan -Si, , South Korea
Inha University Hospital
Incheon, , South Korea
Gachon University Gil Hospital
Incheon, , South Korea
Chonbuk National University Hospital
Jeonju, , South Korea
Yeungnam University Medical Center
Nam-gu, , South Korea
Seoul National University Bundang Hospital
Seongnam-si, , South Korea
Seoul National University Hospital / Department of Internal Medicine
Seoul, , South Korea
Kangbuk Samsung Hospital
Seoul, , South Korea
Severance Hospital, Yonsei University Health System
Seoul, , South Korea
Kyung Hee University Medical Center
Seoul, , South Korea
KyungHee University Medical Center
Seoul, , South Korea
Samsung Medical Center, Dept. of Medicine, Div. of Hematology/Oncology
Seoul, , South Korea
Samsung Medical Center/Division of Hematology-Oncology, Department of Medicine
Seoul, , South Korea
Gangnam Severance Hospital, Yonsei University Health System
Seoul, , South Korea
Korea University Anam Hospital
Seoul, , South Korea
Asan Medical Center/Department of Oncology
Seoul, , South Korea
Asan Medical Center
Seoul, , South Korea
Korea Cancer Center Hospital
Seoul, , South Korea
Korea University Guro Hospital
Seoul, , South Korea
Ewha Womans University Mokdong Hospital
Seoul, , South Korea
Seoul National University Hospital
Seoul, , South Korea
Seoul ST. Mary's Hospital
Seoul, , South Korea
Ulsan University Hospital
Ulsan, , South Korea
Yonsei University Wonju College of Medicine, Wonju Christian Hospital
Wŏnju, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A6181146
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.